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The post-translational attachment of biotin and lipoic
acid to specific lysine residues displayed in protruding
b-turns in homologous biotinyl and lipoyl domains of
their parent enzymes is catalysed by two different
ligases. We have expressed in Escherichia coli a sub-
gene encoding the biotinyl domain of E.coli acetyl-CoA
carboxylase, and by a series of mutations converted
the protein from the target for biotinylation to one for
lipoylation, in vivo and in vitro. The biotinylating
enzyme, biotinyl protein ligase (BPL), and the lipoyl-
ating enzyme, LplA, exhibited major differences in
the recognition process. LplA accepted the highly
conserved MKM motif that houses the target lysine
residue in the biotinyl domain b-turn, but was respons-
ive to structural cues in the flanking b-strands. BPL
was much less sensitive to changes in these b-strands,
but could not biotinylate a lysine residue placed in the
DKA motif characteristic of the lipoyl domain b-turn.
The presence of a further protruding thumb between
the b2 and b3 strands in the wild-type biotinyl domain,
which has no counterpart in the lipoyl domain, is
sufficient to prevent aberrant lipoylation in E.coli. The
structural basis of this discrimination contrasts with
other forms of post-translational modification, where
the sequence motif surrounding the target residue can
be the principal determinant.
Keywords: biotin/biotinyl protein ligase/lipoic acid/lipoyl
protein ligase/protein domains
Introduction
Biotin and lipoic acid are the covalently bound cofactors
of several multicomponent enzyme complexes that cata-
lyse key metabolic reactions. The lipoate and biotin
moieties are attached in amide linkage through their
carboxyl group and the N6-amino group of a specific
lysine residue in the relevant protein, thereby creating
potential swinging arms capable of spanning some 3 nm.
These mobile arms are required to shuttle catalytic inter-
mediates between the successive active sites of the enzyme
complexes. Biotin carries carboxy groups in the ATP-
dependent carboxylases (Samols et al., 1988; Knowles,
1989), whereas lipoic acid serves as an acyl group carrier
in the ubiquitous 2-oxo acid dehydrogenase multienzyme
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complexes (Reed, 1974; Perham, 1991; Berg and de Kok,
1997) or as an aminomethyl group carrier in the glycine
cleavage system (Fujiwara et al., 1979; Kikuchi and
Hiraga, 1982). In 2-oxo acid dehydrogenase complexes,
the lipoyl group is attached to a lysine residue in one or
more independently folded (lipoyl) domains of ~80 amino
acid residues that constitute the N-terminal part of the
dihydrolipoyl acyltransferase (E2) component (Reed and
Hackert, 1990; Perham 1991; Berg and de Kok, 1997).
The structure of the lipoyl domain from several different
2-oxo acid dehydrogenase complexes has been solved by
nuclear magnetic resonance (NMR) spectroscopy (Dardel
et al., 1993; J.D.F.Green et al., 1995; Berg et al., 1996,
1997; Ricaud et al., 1996; Howard et al., 1998). It consists
of a flattened 8-stranded β-barrel containing two 4-stranded
anti-parallel β-sheets, with the N- and C-termini close
together in one sheet and the lipoyl–lysine residue promin-
ently displayed in a tight β-turn in the other (Figure 1).
A similar structure occurs in the lipoylated H-protein
(GCSH) of the glycine cleavage system (Brocklehurst and
Perham, 1993; Pares et al., 1994) but with the β7 strand
missing, the exposed loop connecting the β1 and β2
strands of the lipoyl domain replaced by a helix, and an
additional helix at the C-terminal end (Figure 1D).
Despite minimal conservation of amino acid sequence,
biotinylated proteins also contain a domain similar in
structure to the lipoyl domain (Brocklehurst and Perham,
1993). The structure of the biotinyl domain of the biotin
carboxy carrier protein (BCCP) of acetyl-CoA carboxyl-
ase, the only biotinylated protein of Escherichia coli, has
been established by X-ray crystallography (Athappilly and
Hendrickson, 1995) and NMR spectroscopy (Roberts et al.,
1999). It is also a flattened β-barrel, comprising two 4-
stranded antiparallel β-sheets, with the biotinyl–lysine
residue located in the exposed β-turn between
β-strands 4 and 5 (Figure 1A). Based on sequence align-
ments (Samols et al., 1988), it is likely that all biotinylated
proteins contain an homologous biotinyl domain, a view
supported by NMR spectroscopy of the biotinyl domain
of Propionibacterium shermanii transcarboxylase (Reddy
et al., 1998).
Biotinylation and lipoylation are both post-translational
modifications. Biotin is attached to its target proteins by
the action of biotinyl protein ligase (BPL), also known as
biotin holoenzyme synthetase (Wood et al., 1980). This
enzyme catalyses the activation of biotin to biotinyl-59-
AMP at the expense of ATP and then transfers the biotinyl
group to a specific lysine residue in the biotinyl domain
(a reaction mechanism akin to that of an aminoacyl tRNA
synthetase). In E.coli, the reaction is mediated by the BirA
protein, which also acts as the repressor of the biotin
operon (Barker and Campbell, 1981; Cronan, 1989). The
BirA gene has been sequenced (Howard et al., 1985) and
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Fig. 1. Three-dimensional structures of biotinyl and lipoyl domains. (A) Biotinyl domain from the BCCP of E.coli acetyl-CoA carboxylase
(Athappilly and Hendrickson, 1995); (B) hybrid lipoyl domain from E.coli E2p (J.D.F.Green et al., 1995); (C) lipoyl domain from E.coli E2o
(Ricaud et al., 1996); and (D) H-protein from the glycine cleavage system of pea leaves (Pares et al., 1994). The two β-sheets of the structures are
shown in red and green, and the lysine residue that becomes biotinylated or lipoylated is indicated. The β-strands of the biotinyl domain are
numbered from the N-terminus, and the loop (thumb) region between strands β2 and β3 is shown in blue. The figures were constructed using the
programme MOLSCRIPT (Kraulis, 1991).
the crystal structure of the protein established (Wilson
et al., 1992). Lipoylation is similar but more complicated.
In E.coli, the products of the lplA and lipB genes catalyse
independent pathways of post-translational modification
(Morris et al., 1995). The lipoyl protein ligase LipB uses
endogenous lipoyl–acyl carrier protein from the fatty acid
biosynthesis pathway as the donor of the lipoyl group (Jor-
dan and Cronan, 1997), whereas lipoyl protein ligase A
(LplA) makes use of exogenous lipoic acid in a reaction
formally identical to that of BPL and is responsible for most
of the lipoylation under such conditions (Morris et al., 1994,
1995). Its preferred substrate is D-lipoic acid although it can
also use L-lipoic and octanoic acid (Morris et al., 1994;
D.E.Green et al., 1995). It has no obvious similarity, apart
from the chemistry of its mechanism, to BPL.
Biotinyl and lipoyl protein ligases do not require full
length apo-proteins as substrates, being able to modify
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excised lipoyl and biotinyl domains (Ali and Guest, 1990;
Cronan, 1990; Dardel et al., 1990; Quinn et al., 1993,
Berg et al., 1994, 1995; Reche et al., 1998), but a folded
domain appears to be required (Murtif and Samols, 1987;
Cronan, 1990; Reed and Cronan, 1991). The means by
which the enzymic machinery of the cell can distinguish
between homologous lipoyl and biotinyl domains for
correct post-translational modification is unclear. Accurate
positioning of the target lysine residue in its tight β-turn
in the structure is essential for both lipoylation (Wallis
and Perham, 1994) and biotinylation (Reche et al., 1998),
but the residues flanking the target lysine in the lipoyl
domain are not crucial to the action of LplA. Replacing
the DKA sequence at the tip of the β-turn in the Bacillus
stearothermophilus lipoyl domain with the MKM sequence
found in virtually all biotinylated proteins (Duval et al.,
1994) does not bring about biotinylation of the domain in
Biotinylation and lipoylation of protein domains
Fig. 2. Structure-based alignment of the amino acid sequences of the biotinyl domain from E.coli BCCP and lipoyl domains and H-proteins from
diverse sources. Eco_BCCP, biotinyl domain of E.coli BCCP of acetyl-CoA carboxylase (AC P02905); Psh_Tran, biotinyl domain of P.shermanii
methylmalonyl-CoA carboxyl transferase (1.3S subunit of transcarboxylase) (AC P02904); Eco_E2p1, Eco_E2p2 and Eco_E2p3, outer (N-terminal),
middle and innerlipoyl domains , respectively, of E.coli E2p (AC P06959); Avi_E2p1, outer (N-terminal) lipoyl domain of Azotobacter vinelandii
E2p (AC P10802); Bst_E2p, lipoyl domain of B.stearothermophilus E2p (AC P11961); Eco_E2o, lipoyl domain of E.coli E2o (AC P07016);
Avi_E2o, lipoyl domain of A.vinelandii E2o (AC P20708); Eco_gcsh, lipoyl domain of E.coli H-protein (AC P23884); Pea_GCSH, lipoyl domain of
pea leaf H-protein (AC P16048); Bov_GCSH, lipoyl domain of ox H-protein (AC P20821). Accession numbers are given for the SwissProt Data
Base. The numbering is that of the excised E.coli BCCP biotinyl domain (as in Figure 6) and its β-strands are represented in extent and direction by
numbered arrows above the amino acid sequence (solid arrows, red strands in Figure 1; broken arrows, green strands in Figure 1). Identical residues
are shown in bold and the post-translationally modified lysine residue is marked with an asterisk. The amino acid substitutions created in the Q54E,
SMEP and DASMEP mutant biotinyl domains are indicated. Residues located at position 14 and –3 with respect to the target lysine (K50 for the
biotinyl domain) are shadowed, as are the seven residues deleted in the loop deletion (LD) mutant. The alignment was built using the known
structures of the E.coli BCCP biotinyl domain (Athappilly and Hendrickson, 1995; Roberts et al., 1999), B.stearothermophilus E2p lipoyl domain
(Dardel et al., 1993); E.coli E2p hybrid lipoyl domain (J.D.F.Green et al., 1995), A.vinelandii E2p lipoyl domain (Berg et al., 1997); E.coli E2o
lipoyl domain (Ricaud et al., 1996) and A.vinelandii E2o lipoyl domain (Berg et al., 1996) using the command MALIGN3D from the Modeller
package (Saˆli and Blundell, 1993) and then optimized manually aided by visual inspection of the structures on a graphics terminal.
E.coli (Wallis and Perham, 1994), whereas introduction of
the DKA motif into the BCCP biotinyl domain eliminates
biotinylation and leads to low levels of lipoylation and
aberrant octanoylation (Reche et al., 1998).
We show here that the rational introduction of a set of
amino acid replacements in the biotinyl domain of E.coli
BCCP can switch its specificity as a substrate for post-
translational modification, rendering it ineffective as a
target for biotinylation but highly effective in provoking
lipoylation. We further show that there exists a structural
feature in the natural biotinyl domain, viz a surface
loop between β-strands 2 and 3 that is absent from the
homologous lipoyl domain, which acts to prevent the
aberrant lipoylation of the biotinyl domain in vivo and
in vitro. These results are in striking contrast with the
specificity of other forms of post-translational modifica-
tion, such as phosphorylation, where the sequence motif
surrounding the target residue is often of paramount
importance.
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Results
Rationale for directed mutagenesis
The lysine residue targeted for post-translational modifica-
tion is located in a β-turn in one of the two β-sheets that
constitute both the biotinyl and lipoyl domains (Figure 1).
It was reasonable to suppose that this region more generally
might contain structural features that permit the ligases
BPL and LplA to recognise their respective substrates.
Therefore, we first identified key differences between the
domains in the β-sheet that contains the swinging arm
and then considered amino acid replacements in the E.coli
biotinyl domain that would make it more closely resemble
the lipoyl domain. In the Q54E mutant, the Gln residue
(Q54) in the β5 strand at position 14 with respect to the
target lysine (K50) of the biotinyl domain was replaced
with Glu, since an exposed negatively charged side chain
is found at this position in all lipoyl domains (Figure 2).
The SMEP mutant biotinyl domain was designed to carry
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Table I. Molecular masses of E.coli wild-type and mutant biotinyl domains determined by mass spectrometry
Domain Apo-form (Da): Growth medium supplemented Growth medium supplemented
measured (calculated) with biotin: modified form (Da) with lipoic acid: modified form (Da)
Wild-type 8978.3 6 0.5 (8978.3) 9204 6 1 9204.0 6 0.3
Q54E 8979.4 6 0.1 (8979.3) 9205.4 6 0.2 9168 6 1a
9206 6 2b
SMEP 8920.6 6 1.0 (8920.2) 9146.3 6 0.5 9109 6 1a
9146 6 1b
DASMEP 8844.4 6 0.3 (8844.0) 9032.6 6 0.1 9033 6 1
LD 8282.3 6 0.1 (8281.6) 8507 6 1 8470 6 1
aMore abundant modified component.
bLess abundant modified component.
the Q54E mutation plus three additional changes: M52S,
N53M and E56P; these replace further residues in the β5
strand of the biotinyl domain with the corresponding
residues of the three lipoyl domains of E.coli E2p [E2
component of the pyruvate dehydrogenase (PDH) com-
plex] (Figure 2). The DASMEP mutant domain has the
same mutations as the SMEP domain plus two more
substitutions: M49D and M51A; M49 and M51 are the
highly conserved methionine residues that flank the target
lysine in virtually all biotinyl domains (Duval et al.,
1994), whereas Asp and Ala are the corresponding residues
in the E2p lipoyl domains (Figure 2).
The LD mutant biotinyl domain was designed on a
different basis; it was generated by deleting 7 amino
acid residues (TPSPDAK, residues 22–28) from the loop
connecting the β2 and β3 strands of the biotinyl domain,
residues which are not present in any of the lipoyl domains
(Figure 2). These residues generate a protruding ‘thumb’
in the structure of the biotinyl domain, which is close in
space to the β-turn carrying the biotinyl–lysine residue
(Figure 1), and provide the principal sites of contact with
the biotin that localize the swinging arm on the surface
of the protein (Athappilly and Hendrickson, 1995; Roberts
et al., 1999).
Post-translational modification of the wild-type
and mutant biotinyl domains in vivo
The ability of the various biotinyl domains to undergo
post-translational modification in vivo was checked by
expressing the genes encoding them in E.coli cells grown
in Luria–Bertani (LB) medium supplemented with either
d-biotin (10 mg/l) or dl-lipoic acid (10 mg/l). The purified
domains were analysed by means of non-denaturing 20%
PAGE, in which the modified (holo-) form can be separated
from the apo-form because it carries one fewer positive
charge and therefore migrates more rapidly towards the
anode. The molecular masses of the domains were also
determined by means of electrospray mass spectrometry
(ESMS). The nature and extent of the modification of the
different domains (lower band in each lane in Figure 3)
was found to vary with the growth medium.
The wild-type biotinyl domain was observed to be
biotinylated in cells grown in medium supplemented with
either biotin or lipoic acid, as judged by the molecular
mass of the modified protein band; in both instances, the
molecular mass was 226 Da more than that of the apo-
domain (Table I), corresponding to addition of a biotinyl
group (Krishna and Wold, 1993). However, the biotinylated
product represented ~90% of the total domain when the
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Fig. 3. Post-translational modification of the E.coli wild-type and
mutant biotinyl domains in vivo. Wild-type and mutant biotinyl
domains were isolated from E.coli BL21(DE3) cells transformed with
the relevant plasmid and grown in the presence of either d-biotin (10
mg/l, bio) or DL-lipoic acid (10 mg/l, lip). Approximately 3 µg of
each domain was subjected to non-denaturing PAGE (20% gels) and
stained with Coomassie Brilliant Blue. Lanes 1 and 2, wild-type
biotinyl domain (WT); lanes 3 and 4, Q54E mutant biotinyl domain
(Q54E); lanes 5 and 6, SEMP mutant biotinyl domain (SMEP); lanes
7 and 8, DASMEP mutant biotinyl domain (DASMEP); lanes 9 and
10, LD mutant biotinyl domain (LD). In each lane, the upper band is
the apo-form of the domain and the lower band is the post-
translationally modified form.
gene was expressed in the presence of biotin (Figure 3,
lane 1) but only 15% when the gene was expressed in the
same medium supplemented with lipoic acid (Figure 3,
lane 2). The Q54E mutant domain isolated from E.coli
cells grown in a medium supplemented with biotin was
also modifed to a similar extent (80%) as the wild type
(Figure 3, lane 3), and the difference in molecular mass
compared with the wild type (226 Da) was again indicative
of biotinylation (Table I). In contrast, the same mutant
domain obtained from cells grown in medium supple-
mented with lipoic acid was modified to a lesser extent,
~30% (Figure 3, lane 4), and the increase in mass of the
modified form (188 Da; Table I) corresponded with that
of a lipoyl group (Krishna and Wold, 1993). A minor
component (,10% of the modified product, as judged
from the mass spectrum) was also detected, with the
molecular mass (9206 6 2 Da) of the biotinylated form
of the domain.
The SMEP mutant domain isolated from cells grown
expressed in the medium supplemented with biotin was
90% in the modified form (Figure 3, lane 5) and the
molecular mass was that expected for the biotinylated
domain. On the other hand, when isolated from cells
grown in a medium supplemented with lipoic acid, 60%
of the mutant domain was modified (Figure 3, lane 6) and
the mass spectrum of the heavier component indicated a
lipoylated product (Table I). A trace (5%) of the biotinyl-
ated SMEP domain was also identified from the mass
spectrum (Table I). The DASMEP mutant domain isolated
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from E.coli cells grown in a medium supplemented with
biotin had become modified to a level of only 15% (Figure
3, lane 7) and the molecular mass of the modified protein
corresponded with lipoylation, not biotinylation (Table I).
The same domain was found to be modified to approxi-
mately the same extent (70%) as the SMEP mutant
when purified from E.coli cells grown in LB medium
supplemented with lipoic acid (Figure 3, lane 8), and
ESMS gave only one molecular mass: that expected for
the lipoylated protein (Table I).
The LD mutant domain differs from the previous
mutants in that its only change is the deletion of the
protruding thumb region between β-strands 2 and 3.
When it was purified from E.coli cells grown in medium
supplemented with biotin, it was found to be modified to
a level of 55% (Figure 3, lane 9) and the mass spectrum
corresponded with that of the biotinylated form of the
domain. Likewise, .90% of the LD mutant domain
obtained from cells grown in LB medium supplemented
with lipoic was modified (Figure 3, lane 10), but ESMS
gave a molecular mass that identified the modification as
only lipoylation (Table I).
Post-translational modification of the wild-type
and mutant biotinyl domains in vitro
The biotinylation and lipoylation of the various biotinyl
domains in vitro were studied with the purified ligases,
BPL and LplA. The incubation times were fixed at 1 h
but the amount of ligase was varied and the products were
separated by 20% non-denaturing PAGE. The extent
of the modification, as judged by densitometry of the
Coomassie Blue-stained gels, was plotted against the
amount of either BPL or LplA. The slopes of these plots
give a measure of the ability of the domains to undergo
post-translational modification, expressed as percent modi-
fication per microgramme of ligase (see Materials and
methods for details).
When tested as a substrate for LplA in the presence of
lipoic acid, the wild-type biotinyl domain (Figure 4A)
was observed to undergo lipoylation at a very slow rate,
reaching only 40% modification in the presence of the
maximum amount (10 µg) of ligase, a difference of
1000-fold in comparison with the wild-type E2p lipoyl
domain (Figure 4F). The susceptibility to lipoylation was
increased 10-fold by the introduction of the Q54E mutation
(Figure 4B) and ~35-fold for both the SMEP and DASMEP
mutant domains (Figure 4C and D). It increased substan-
tially again (~340-fold) for the LD mutant biotinyl domain,
coming close to the rate (a difference of no more than
3-fold) that we observed for the wild-type E2p lipoyl
domain (Figure 4E). These results are summarized in
Figure 4G.
In contrast, when tested as a substrate for biotinylation
by BPL, the Q54E mutant domain was only slightly less
effective than the wild-type biotinyl domain (Figure 5A
and B). The biotinylation of the SMEP mutant domain
was also comparable with that of the wild-type biotinyl
domain (Figure 5C) whereas that of the DASMEP domain
was badly affected, being scarcely detectable under the
chosen conditions (Figure 5D). On the other hand, the
LD mutant domain remained a good substrate for BPL,
requiring only twice the amount of BPL to achieve the
same modification as the wild-type domain (Figure 5E).
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Fig. 4. Lipoylation of the E.coli biotinyl domains with LplA in vitro.
Samples (2 µg) of purified apo-form of each biotinyl domain was
incubated for 1 h with lipoic acid and differing amounts of LplA
under the conditions described in Materials and methods and the
products were analysed by means of non-denaturing PAGE (20% gels).
The gels were stained with Coomassie Blue. (A) Wild-type biotinyl
domain (WT) was incubated withouth LplA (lane 1) and with 4 µg
LplA (lane 2), 6.6 µg LplA (lane 3) and 10 µg LplA (lane 4).
(B)Q54E mutant biotinyl domain (Q54E) was incubated without LplA
(lane 1), and with 0.25 µg LplA (lane 2), 0.5 µg LplA (lane 3) and
1.0 µg LplA (lane 4). (C) SMEP mutant biotinyl domain was
incubated without LplA (lane 1) and with 0.25 µg LplA (lane 2),
0.33 µg LplA (lane 3) and 0.5 µg LplA (lane 4). (D) DASEMP
mutant biotinyl domain was incubated without LplA (lane 1) and with
0.25 µg LplA (lane 2), 0.33 µg LplA (lane 3) and 0.5 µg LplA
(lane 4). (E) LD mutant biotinyl domain was incubated without LplA
(lane 1) and with 0.02 µg LplA (lane 2), 0.03 µg LplA (lane 3) and
0.05 µg LplA (lane 4). (F) Lipoyl domain (innermost) of E.coli E2p
was incubated without LplA and with 0.008 µg LplA (lane 2), 0.01 µg
LplA (lane 3), 0.013 µg LplA (lane 4) and 0.02 µg LplA (lane 5). The
extent (%) of lipoylation was determined densitometrically and plotted
against the quantity (µg) of LplA present in the reaction mixture.
(G) Dotted line, wild-type biotinyl domain; m, Q54E mutant biotinyl
domain; d, SMEP mutant biotinyl domain; s, DASMEP mutant
biotinyl domain; j, LD mutant biotinyl domain; u, E2p lipoyl
domain.
These results are summarized in Figure 5F. Overall, the
results of lipoylation and biotinylation with the purified
ligases in vitro were fully consistent with those obtained for
the post-translational modifications of the domains in vivo.
Discussion
Post-translational modification of specific lysine residues
in the biotinyl and lipoyl domains of biotin- and lipoic
acid-dependent enzymes is essential for their proper func-
tion. The biotinyl and lipoyl protein ligases have similar
mechanisms but no obvious structural similarity. The
biotinyl and lipoyl domains are closely related in three-
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Fig. 5. Biotinylation of the E.coli biotinyl domains with BPL in vitro.
Samples (2 µg) of purified apo-form of each biotinyl domain was
incubated for 1 h with biotin and differing amounts of BPL under the
conditions described in Materials and methods and the products were
analysed by means of non-denaturing PAGE (20% gels). The gels
were stained with Coomassie Blue. (A) Wild-type biotinyl domain
(WT) was incubated without BPL (lane 1) and with 0.0035 µg BPL
(lane 2), 0.007 µg BPL (lane 3), 0.0093 µg BPL (lane 4) and 0.014 µg
BPL (lane 5). (B) Q54E mutant biotinyl domain (Q54E) was incubated
with no BPL (lane 1) and with 0.007 µg BPL (lane 2), 0.0093 µg BPL
(lane 3) and 0.014 µg BPL (lane 4). (C) SMEP mutant biotinyl
domain was incubated without BPL (lane 1) and with 0.0093 µg BPL
(lane 2) and 0.014 µg BPL (lane 3). (D) DASMEP mutant biotinyl
domain was incubated without BPL (lane 1) and with 0.0093 µg BPL
(lane 2) and 0.014 µg BPL (lane 3). (E) LD mutant biotinyl domain
was incubated without BPL (lane 1) and with 0.0093 µg BPL (lane 2),
0.0175 µg BPL (lane 3) and 0.023 µg BPL (lane 4). The extent (%) of
biotinylation was determined densitometrically and plotted against the
quantity (µg) of BPL present in the reaction mixture. (F) Dotted line,
DASMEP mutant biotinyl domain; m, wild-type biotinyl domain;
d, Q54E mutant biotinyl domain; n, SMEP mutant biotinyl domain;
s, LD mutant biotinyl domain.
dimensional structure, and there must therefore be one or
more key differences between them to ensure their correct
selection. In the E.coli cell there is only one biotinylated
protein, the BCCP of acetyl-CoA carboxylase, but this
exists alongside several lipoyl domains from the PDH
and 2-oxoglutarate dehydrogenase (2OGDH) multienzyme
complexes, and the GCSH. We are now in a position
to understand how the necessary specificity of post-
translational modification is achieved.
Thus, when a sub-gene expressing the biotinyl domain
of the BCCP was overexpressed in E.coli cells growing
in a medium supplemented with either biotin or lipoic
acid, only the biotinylated form of the domain was
obtained, although in the cells grown with lipoic acid
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the extent of modification was much lower (Figure 3).
Likewise, with a large excess of purified E.coli LplA, the
biotinyl domain could be lipoylated in vitro but compared
very poorly with an E.coli E2p lipoyl domain (Figure 4).
However, the introduction of the Q54E mutation in the
β5 strand of the biotinyl domain (Figures 1 and 2)
predominantly (25%) led to lipoylation of the domain
in vivo in cells grown in lipoic acid-containing medium,
accompanied by only 5% or less of biotinylation, although
the domain was still extensively biotinylated if the growth
medium were supplemented with biotin (Figure 3). Under
these conditions, the lipoylation in vivo is likely to be due
to LplA, since this enzyme utilizes free lipoic acid (Morris
et al., 1995). Indeed, the Q54E mutation rendered the
biotinyl domain a much better substrate for LplA in vitro,
although it was still substantially poorer than the wild-
type E2p lipoyl domain (Figure 4) and remained an
effective substrate for BPL (Figure 5). A negatively
charged Glu or Asp residue is found at this surface-
exposed position in all lipoylated proteins (Figure 2) and
our results make it clear that its replacement with Gln in
the biotinyl domain of E.coli BCCP helps to prevent that
protein from acting as a substrate for LplA in vivo
or in vitro.
Lipoylation of the biotinyl domain was further improved
by exchanging additional residues in the β5 strand for their
counterparts in the E.coli E2p lipoyl domains (Figure 2).
Lipoylation of the SMEP domain in cells grown in the
presence of lipoic acid was doubled, with only a residual
trace of biotinylation, but again without effect on the
extent of biotinylation observed when the growth medium
was supplemented with biotin (Figure 3). Corresponding
effects were noted when the SMEP domain was tested as
a substrate for LplA (Figure 4) or BPL (Figure 5) in vitro.
The secondary importance of residues that neighbour
Gln54 in the β5 strand for recognition by LplA is obvious.
The hydrophobic residue, Ile55, adjacent to Gln54 is
unlikely to be involved, since it participates in forming
the hydrophobic core of the domain (Athappilly and
Hendrickson, 1995; Roberts et al., 1999), as does the
corresponding residue (always a hydrophobic side chain)
in the lipoyl domain (Dardel et al., 1993; J.D.F.Green
et al., 1995). Unlike LplA, BPL is evidently rather
indifferent to the nature of the amino acid side chains in
the β5 strand, though not of course to their contribution
to the correct protein fold [in accordance with other
evidence coming from a study of the interaction by
means of NMR spectroscopy (P.A.Reche, M.J.Howard
and R.N.Perham, unpublished work)].
In the DASMEP biotinyl domain, the two methionine
residues that flank the target lysine residue in virtually all
biotinyl domains (Duval et al., 1994) were replaced with
the residues that occupy these positions in the β-turn of
the E.coli lipoyl domains (Figure 2). The effect on
biotinylation was substantial: the DASMEP domain was
no longer biotinylated in vivo, even in E.coli cells grown
in the presence of biotin (Figure 3), nor was it biotinylated
by BPL in vitro (Figure 5). However, its ability to become
lipoylated by LplA in vitro was unchanged (Figure 4).
These results suggest that LplA has no particular prefer-
ence for the residues that flank the target lysine residue,
as inferred from studies of the lipoylation of the
B.stearothermophilus E2p lipoyl domain in E.coli cells
Biotinylation and lipoylation of protein domains
in vivo (Wallis and Perham, 1994). They are also consistent
with the observation (Reche et al., 1998) that the double
mutation M49DM51A is itself sufficient to inhibit biotinyl-
ation of the E.coli BCCP biotinyl domain in vivo and
in vitro. Replacement of the two methionine residues with
other hydrophobic residues has been reported to have no
major effect on the biotinylation of other biotinylated
proteins tested in E.coli (Shenoy et al., 1988; Leon-Del-
Rio and Gravel, 1994). Thus it would appear that BPL
responds only to certain changes in residues flanking the
target lysine and, given that the corresponding sequence in
the lipoyl domain of the dihydrolipoyl succinyltransferase
(E2o) of the 2OGDH complex is DKV, that it may be the
negatively charged Asp side-chain that is of particular
importance in preventing recognition by BPL.
The protruding thumb region between strands β2 and
β3 of the E.coli BCCP biotinyl domain does not exist in
the E.coli lipoyl domains (Figure 1). The LD mutant
biotinyl domain, in which the seven residues (Thr22 to
Lys28) that constitute this loop (Figure 2) were deleted,
proved to be almost as efficient a substrate as the native
E2p lipoyl domain for lipoylation in vivo (Figure 3) and
by LplA in vitro (Figure 4). This is true notwithstanding
the presence of Gln rather than Glu at position 54 in
strand β5 (see above). At the same time, the LD domain
retained significant ability to undergo biotinylation, in vivo
(Figure 3) and in vitro (Figure 5). Thus, the protruding
thumb between strands β2 and β3 is not critical for the
interaction with BPL but its presence is sufficient to
prevent the biotinyl domain from becoming lipoylated.
This effect may be limited to E.coli, since the amino acids
that constitute the thumb are not present in most other
biotinyl domains (Reddy et al., 1998).
The biotinyl–lysine residue is immobilized in E.coli
BCCP, both in the crystal (Athappilly and Hendrickson,
1995) and solution NMR (Roberts et al., 1999) structures,
as a result of interactions between the biotin moiety and
amino acid residues in the thumb region. In other biotinyl
domains the protruding thumb is absent and, at least in
the biotinyl domain from P.shermanii transcarboxylase
(Reddy et al., 1997), NMR spectroscopy suggests that the
biotinyl–lysine residue is free to move. Similarly, the
lipoyl–lysine residue is essentially free to move on the
surface of the lipoyl domain in the 2-oxo acid dehydro-
genase complexes, as judged by NMR (Dardel et al.,
1993) and other spectroscopic techniques (Ambrose and
Perham, 1976; Grande et al., 1976). However, the lipoyl–
lysine in the GCSH protein of pea leaves is localized by
interactions with the protein in the oxidized form (Pares
et al., 1994), and has moved to a different but again
localized position with a different set of interactions in
the charged (reductively aminomethylated) form (Cohen-
Addad et al., 1995). The immobilization of the swinging
arm in the GCSH protein appears to be associated with
the protection of an unstable catalytic intermediate, exem-
plifying the ‘hot potato’ hypothesis (Perham and Reche,
1998). In the present context, it is of particular interest that
the structural feature responsible for the immobilization of
the biotinyl–lysine swinging arm in the E.coli BCCP
is also sufficient to prevent aberrant post-translational
modification of the target lysine residue.
There are hints of parallels in other organisms. In ox
liver mitochondria, two isoforms of lipoyltransferase have
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been identified as catalysing the lipoylation of proteins
using lipoyl-59-AMP as the lipoyl group donor, but are
unable to use lipoic acid and MgATP for lipoylation,
suggesting that a second enzyme may be required to
initiate the lipoylation reaction in ox liver (Fujiwara et al.,
1994). An E63D mutation in ox GCSH does not affect
the lipoylation of this protein by ox lipoyltransferase,
whereas the mutation E63Q decreases it 4-fold (Fujiwara
et al., 1991). Glu63 in ox GCSH corresponds to Gln54 in
the E.coli biotinyl domain (Figure 2), suggesting that ox
lipoyltransferase, like E.coli LplA, has a preference for a
domain with a negatively charged side chain at position
14 with respect to the target lysine residue. Likewise, a
Glu at position –3 is crucial for lipoylation mediated by
ox lipoyltransferase (Fujiwara et al., 1996). Glu47 is
present in the corresponding position of the E.coli lipoyl
domains and BCCP biotinyl domain (Figure 2), but in the
BCCP protein it is unlikely to be accessible to LplA
because of shielding by the protruding thumb (Figure 1).
When the thumb is deleted, Glu47 should become fully
exposed, which may facilitate the lipoylation of the
LD domain.
Structural cues are thus seen to dominate the recognition
of the homologous biotinyl and lipoyl domains by two
ligases, which are themselves structurally different; Bpl
and LplA clearly recognise different structural features in
separate locations on these closely similar proteins. Our
results are in striking contrast to other forms of post-
translational modification, where the amino acid sequence
surrounding the target residue can be of crucial importance
and unstructured synthetic peptides are adequate sub-
strates.
Materials and methods
Materials
All chemicals used were of reagent grade or better. Bacterial growth
media were purchased from Oxoid, Unipath Laboratories. Escherichia
coli host strain SURE® was from Stratagene, and strains BL21(DE3)
and BL21(DE3)plysS were from Novagen. dl-lipoic acid and
d-biotin were purchased from Sigma. Restriction endonucleases and
DNA modifying enzymes were from Pharmacia Biotech and New
England Biolabs, Inc.; Pfu DNA polymerase was purchased from
Stratagene Ltd. Oligonucleotide primers were synthesized by
Mr M.Weldon in the Protein and Nucleic Acid Facility, Department of
Biochemistry, University of Cambridge, UK.
Expression plasmids
Plasmid pTbpl carrying the gene encoding the BPL of E.coli was
constructed by P.Reche and R.N.Perham (unpublished work). Plasmid
TM202 (Morris et al., 1994) carrying the gene encoding LplA was
generously provided by Dr J.E.Cronan, Jr (University of Illinois, IL).
Plasmid pET11cE2p expressing a subgene encoding the innermost lipoyl
domain of the E2p chain of E.coli PDH complex (Packman et al., 1984)
was constructed by E.L.Roberts and R.N.Perham (unpublished work).
Plasmid pGsthBCCP, carrying DNA encoding the biotinyl domain from
the BCCP of E.coli acetyl-CoA carboxylase (P.Reche and R.N.Perham,
unpublished work), generates a fusion protein with glutathione
S-transferase (GST) at the N-terminus, followed by a thrombin cleavage
site and the biotinyl domain. The DNA encoding the biotinyl domain in
pGsthBCCP was engineered with several silent mutations that introduce
three new unique restriction sites (HindIII, NsiI and BspEI) to facilitate
cassette mutagenesis. The DNA sequence of the modified sub-gene
encoding the biotinyl domain is shown in Figure 6.
DNA manipulations
Standard protocols for molecular biology were used as described else-
where (Sambrook et al., 1989). DNA fragments were purified after
agarose gel electrophoresis using a Geneclean® kit (BIO101). A Qiagen
P.Reche and R.N.Perham
Fig. 6. DNA sequence of the modified sub-gene encoding the biotinyl domain in pGsthBCCP. The amino sequence of the biotinyl domain is given
beneath the DNA sequence. Unique restriction sites are italicized, with the name of the enzyme above the DNA sequence. The mutations introduced
in the sub-gene in order to generate the restriction sites for HindIII, NsiI and BspEI are underlined. The biotinyl domain sub-gene was cloned into
the BamHI and EcoRI restriction sites (shown in lower case) of pGEX-2T. The amino acid sequence of the biotinyl domain starts at Ala3; Gly1 and
Ser2 are derived from the construction of the expression plasmid and the thrombin cleavage (see text for details). The target residue for biotinylation
is Lys50, in the sequence MKM.
Table II. Oligonucleotides used for the cassette mutagenesis
Cassette Name Sequence
smep sen-smep 59-TCGTTGAAGCCATGAAAATGTCGATGGAAATCCCGGCGGACAAATCCGGTAC
ant-smep 59-CGGATTTGTCCGCCGGGATTTCCATCGACATTTTCATGGCTTCAACGATGCA
dasmep sen-dasmep 59-TCGTTGAAGCCGACAAAGCATCGATGGAAATCCCGGCGGACAAATCCGGTAC
ant-dasmep 59-CGGATTTGTCCGCCGGGATTTCCATCGATGCTTTGTCGGCTTCAACGATGCA
ld sen-ld 59-GTACGTTCCCCGATGGTTGGTACTTTCTACCG
ant-ld 59-AGCTCGGTAGAAAGTACCAACCATCGGGGAAC
kit was used for plasmid isolation. Automated DNA sequence analysis
was performed by Mr J.Lester and Mrs K.Pennock (Department of
Biochemistry, University of Cambridge, UK). Polymerase chain reactions
(PCRs) were carried out under mineral oil in reaction mixtures (100 µl)
containing 200 µM dNTPs, 2 mM MgCl2, 100 pmol each of sense and
anti-sense primers, 10 ng of DNA template and 2.5 U of Pfu DNA
polymerase. The conditions for PCR were: 5 min at 94°C (1 cycle);
1 min at 94°C, 1 min 30 s at 55°C, 2 min at 72°C (25 cycles); and
10 min at 72°C (1 cycle).
Mutations in the biotinyl domain
The Q54E mutant biotinyl domain was generated by overlap extension
PCR (Ho et al., 1989) using pGsthBCCP DNA as template. The
overlapping primers used were senQ54E, 59-ATGATGAACGAGATCG-
AAGCGGAC, and antQ54E, 59-GTCCGCTTCGATCTCGTTCATCAT
(the codon encoding the substitution is shown in bold), with primers
pGD, 59-CCAGCAAGTATATAGCATGGCCTTTGC, and pGR, 59-AA-
GCTGTGACCGTCTCCGGGAGC priming upstream and downstream,
respectively, of the coding sequence. The final overlapping PCR fragment
was purified after agarose gel electrophoresis, digested with BamHI and
EcoRI, and then cloned into pGEX-2T cut with the same enzymes, to
give the plasmid pGq54esthBCCP. The SMEP, DASMEP and LD mutant
biotinyl domains were generated by means of cassette mutagenesis.
Thus, for the SMEP and DASMEP domains, the 52 bp NsiI–KpnI
fragment in pGsthBCCP was replaced with the synthetic DNA cassettes,
smep and dasmep, respectively (Table II). The smep and dasmep cassettes
both encode the M52S, N53M, Q54E and E56P mutations, but the
dasmep cassette encodes the additional mutations, M49D and M51A.
The LD mutant biotinyl domain was generated by replacing the 53 bp
SplI (BsiWI)–HindIII fragment in pGsthBCCP with a 32 bp synthetic
DNA fragment (ld) (Table II) that creates a deletion of seven amino
acid residues from Thr22 to Lys28, inclusive. The mutagenic cassettes
were cloned into pGsthBCCP cut with the appropriate restriction enzymes
to give the plasmids pGsmepsthBCCP, pGdasmepsthBCCP and
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pGldsthBCCP. All plasmids were propagated in E.coli SURE® cells and
the DNA sequences of the mutated sub-genes were verified.
Purification of the biotinyl domains and of BPL and LplA
Biotinyl domains were isolated from E.coli BL21(DE3) cells transformed
with the relevant plasmid and grown in LB medium (Sambrook et al.,
1989) containing 100 µg/ml of ampicillin and supplemented with either
d-biotin (10 mg/l) or dl-lipoic acid (10 mg/l). The biotinyl domains were
purified from the cell-free extract as described by Reche et al. (1998).
Further purification of the biotinyl domains to separate the holo- and
apo-forms was carried out by anion-exchange chromatography on a
Pharmacia Resource™ Q HR 16/10 column, also as described by Reche
et al. (1998). The E2p lipoyl domain was purified from E.coli BL21(DE3)
cells transformed with pET11cE2p grown in LB medium containing
100 µg/ml ampicillin, as described by Dardel et al. (1990). BPL was
purified from E.coli BL21(DE3)plysS cells transformed with the plasmid
pTbpl, and LplA was purified from E.coli BL21(DE3) cells transformed
with the plasmid TM102, both as described elsewhere (Reche et al.,
1998).
Kinetics of biotinylation and lipoylation
Biotinylation reactions were carried out in mixtures (15 µl) containing
50 mM Tris–HCl, pH 8.3, 40 mM MgCl2, 2.6 mM ATP (pH 7.0),
200 µM d-biotin and 2 µg of protein substrate. Lipoylation reactions
were carried out in mixtures (15 µl) containing 33 mM potassium
phosphate buffer, pH 7.5, 1.0 mM ATP (pH 7.0), 2.0 mM MgCl2,
200 µM dl-lipoic acid (pH 7.0) and 2 µg of protein substrate. Reactions
were started by adding measured amounts of the relevant ligase (BPL
or LplA) and incubation was at 30°C for 1 h. The extent of the
modification was analysed by means of non-denaturing PAGE (20%
acrylamide, 1% bis-acrylamide as separating gel; 5% acrylamide as
stacking gel). The relative amounts of the modified and unmodified
domains were determined densitometrically from scanned pictures of
the Coomassie-stained gels (using the program Phoretix 1D Advanced,
Biotinylation and lipoylation of protein domains
version 3.0) and the percentage of modified protein (lipoylation or
biotinylation) was plotted against the amount of ligase used in the
particular reaction.
Protein chemical techniques
Protein purifications were carried out on a Pharmacia FPLC™ at 4°C
and column fractions were analysed by means of SDS–PAGE (12.5 and
20% acrylamide) using the Pharmacia PhastSystem™. All gels were
stained with Coomassie Brilliant Blue R-250. The concentrations of pure
proteins were estimated by amino acid analysis (Packman et al., 1988).
Molecular masses of biotinyl domains were obtained by ESMS using a
VG BioQ quadrapole mass spectrometer and myoglobin as the calibration
standard. Protein samples for ESMS were dissolved in 50% acetonitrile,
1% formic acid to a final concentration of ~10 µM.
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